Made in the USA
Allergy and ENT practices must follow USP 797 when mixing patient-specific allergen extracts for subcutaneous immunotherapy (ACAAI 2023). Section 21 of USP 797 details the requirements for allergen extract compounding to reduce the chance of contamination and protect the patient’s overall health. Requirements apply for mixing allergen extracts for allergy testing and regular immunotherapy…. Learn More